Need help finding what you are looking for?
Contact Us
PUBLISHER: Visiongain | PRODUCT CODE: 2037282
PUBLISHER: Visiongain | PRODUCT CODE: 2037282
Global Pharmaceutical Contract Manufacturing Market Report 2026-2036
PUBLISHED:
PAGES: 419 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
The global Pharmaceutical Contract Manufacturing market is projected to grow at a CAGR of 7.9% by 2036.
The Pharmaceutical Contract Manufacturing Market Report 2026-2036 provides a thorough examination of the global market, covering market sizing, demand drivers, competitive dynamics, and revenue projections across key segments and regions.
The global pharmaceutical contract manufacturing market is forecast to grow from US$171.00 billion in 2026 to US$367.06 billion by 2036, at a CAGR of 7.9% over the forecast period. Growth is underpinned by sustained pharmaceutical R&D investment, accelerating outsourcing to contract development and manufacturing organisations (CDMOs), and rising demand for complex biologics and advanced therapeutic modalities.
R&D Investment and Outsourcing Driving Structural Demand
Growing pharmaceutical R&D expenditure is a fundamental structural driver of demand for contract manufacturing services. As pipelines broaden across small molecules, biologics, and emerging modalities - including antibody-drug conjugates and peptides - pharmaceutical companies are increasingly turning to CDMOs for specialist capabilities, capacity flexibility, and accelerated routes to market.
This outsourcing shift enables more efficient capital allocation while compressing development timelines and providing scalable production across both clinical and commercial stages. Ongoing innovation in biologics manufacturing and process development is further cementing the role of outsourcing in the global pharmaceutical value chain.
Trade Flows, Policy Shifts & Supply Chain Pressures
U.S. trade tariffs are expected to reshape the pharmaceutical contract manufacturing market by reconfiguring global supply chains and raising the strategic importance of localised production. Import duties on pharmaceutical products may increase cost pressures on cross-border manufacturing models, prompting companies to prioritise domestic or regionally aligned production strategies.
In response, CDMOs with multi-regional manufacturing networks and integrated service offerings are expected to strengthen their competitive advantage. Demand is likely to migrate towards partners that offer supply chain resilience, regulatory alignment, and operational flexibility across geographies.
Commercial Implications
- Cost and pricing pressure: Tariffs and regulatory requirements are pushing up manufacturing costs
- Supply chain shifts: Companies are broadening their supplier base and building regional production capacity
- Regulatory influence: Compliance obligations continue to govern market access and development timelines
- Competitive positioning: CDMOs with global infrastructure and advanced capabilities are pulling ahead
Company Intelligence
The pharmaceutical contract manufacturing market is intensely competitive, with global CDMOs, niche providers, and integrated pharmaceutical companies all competing across capability, scale, and geographic reach.
Leading players including AbbVie Inc., Lonza, Thermo Fisher Scientific Inc., Samsung Biologics, and WuXi AppTec are consolidating their market positions through capacity expansion, technology investment, and strategic partnership activity.
Competitive differentiation is increasingly driven by:
- Technology capability and specialisation
- Regulatory expertise and compliance
- Global manufacturing footprint
- Ability to support complex and biologics-based production
Emerging players and regional CDMOs are also gaining ground where cost efficiency, niche expertise, or local market presence create meaningful differentiation.
Key Questions Answered
- How is the pharmaceutical contract manufacturing market evolving?
- What are the key drivers and restraints shaping the market?
- How will each segment perform over the forecast period?
- Which regions and countries will lead growth?
- Who are the leading players and how will their strategies evolve?
Report Scope and Data Coverage
- Global pharmaceutical contract manufacturing market analysis
- Revenue forecasts to 2036
- Segment-level modelling across drug type, services, scale of operation, and end-users
- Regional and national market forecasts
- Competitive intelligence on leading companies
Segmentation Framework
By Drug Type
- Branded
- Generics
By Services
- Pharmaceutical Manufacturing Services
Pharmaceutical API Manufacturing Services
Pharmaceutical FDF Manufacturing Services
- Drug Development Services
Lead Identification and Candidate Optimisation
Target Identification and Screening
Target Validation and Functional Informatics
Other Services
- Biologics Manufacturing Services
Biologics API Manufacturing Services
Biologics FDF Manufacturing Services
By Scale of Operation
- Clinical
- Commercial
By End-users
- Big Pharmaceutical Companies
- Small and Medium-sized Pharmaceutical Companies
- Generic Pharmaceutical Companies
- Others
Geographic Coverage
North America
- U.S.
- Canada
Europe
- Germany
- UK
- France
- Italy
- Spain
- Rest of Europe
Asia Pacific
- Japan
- China
- India
- Australia
- Rest of Asia Pacific
Latin America
- Brazil
- Mexico
- Rest of Latin America
Middle East and Africa
- GCC
- South Africa
- Rest of MEA
Why This Market Intelligence Matters
The pharmaceutical contract manufacturing market is undergoing rapid change as outsourcing becomes central to pharmaceutical development and production strategy. Organisations that understand these dynamics will be better placed to capture growth opportunities, optimise supply chains, and sharpen their competitive positioning.
Product Code: PHA1388
Table of Contents
1 Report Overview
- 1.1 Objectives of the Study
- 1.2 Introduction to Pharmaceutical Contract Manufacturing Market
- 1.3 What This Report Delivers
- 1.4 Why You Should Read This Report
- 1.5 Key Questions Answered by This Analytical Report Include:
- 1.6 Who is This Report For?
- 1.7 Methodology
- 1.7.1 Market Definitions
- 1.7.2 Market Evaluation & Forecasting Methodology
- 1.7.3 Data Validation
- 1.7.3.1 Primary Research
- 1.7.3.2 Secondary Research
- 1.8 Frequently Asked Questions (FAQs)
- 1.9 Associated Visiongain Reports
- 1.10 About Visiongain
2 Executive Summary
3 Market Overview
- 3.1 Key Findings
- 3.2 Market Dynamics
- 3.3 Impact Analysis
- 3.3.1 Market Driving Factors
- 3.3.1.1 Patent Expiry and Increasing Demand for Generic Drugs
- 3.3.1.2 Increasing Investments in Pharmaceutical R&D
- 3.3.1.3 Investments in Advanced Manufacturing Technologies by CDMOs
- 3.3.1.4 Increasing Venture-Capital Funded Virtual Biotech
- 3.3.1.5 Accelerating Small and Mid-sized Pharma Outsourcing
- 3.3.2 Market Restraining Factors
- 3.3.2.1 Supply Chain Vulnerabilities
- 3.3.2.2 Varying Regulatory Scenarios
- 3.3.2.3 High Capital Investment Requirements in Pharmaceutical Manufacturing
- 3.3.3 Market Opportunities
- 3.3.3.1 Increasing Demand for Biological Therapies
- 3.3.3.2 Growth in the Nuclear Medicine Sector
- 3.3.3.3 Growing Demand for Cell and Gene Therapies
- 3.3.3.4 Growth Opportunities in Emerging Countries
- 3.3.1 Market Driving Factors
- 3.4 Porter's Five Forces Analysis
- 3.4.1 Bargaining Power of Suppliers
- 3.4.2 Bargaining Power of Buyers
- 3.4.3 Threat of New Entrants
- 3.4.4 Threat of Substitutes
- 3.4.5 Competitive Rivalry
- 3.5 PEST Analysis
- 3.6 U.S. Tariffs: What's the Impact on Global Pharmaceutical Contract Manufacturing Market?
- 3.6.1 Overview
- 3.6.2 V-Shaped Recovery Scenario
- 3.6.3 Why V-Shaped Recovery?
- 3.6.3.1 Impact from Tariffs
- 3.6.3.2 Market Dynamics and Demand Recovery
- 3.6.3.3 Policy and Funding Support
- 3.6.3.4 Timeframe for Recovery
- 3.6.4 U-Shaped Recovery Scenario
- 3.6.4.1 Why U-Shaped Recovery?
- 3.6.4.2 Impact from Tariffs
- 3.6.4.3 Market Dynamics and Demand Recovery
- 3.6.4.4 Policy and Funding Support
- 3.6.4.5 Timeframe for Recovery
- 3.6.5 L Shaped Recovery Scenario
- 3.6.5.1 Why L-Shaped Recovery?
- 3.6.5.2 Impact from Tariffs
- 3.6.5.3 Market Dynamics and Demand Recovery
- 3.6.5.4 Policy and Funding Support
- 3.6.5.5 Timeframe for Recovery
- 3.6.6 What Strategic Considerations Should Clients Factor into Their Near-term (2026-2031) and Long-term (2026-2036) Planning?
- 3.6.7 Impact of U.S. and China Trade War on Pharmaceutical Contract Manufacturing Market
- 3.6.8 How Might the Most Impacted Countries Experience Positive and Negative Effects Resulting from These Policy Changes?
4 Pharmaceutical Contract Manufacturing Market Analysis by Drug Type
- 4.1 Key Findings
- 4.2 Drug Type Segment: Market Attractiveness Index
- 4.3 Pharmaceutical Contract Manufacturing Market Size Estimation and Forecast by Drug Type
- 4.4 Branded
- 4.4.1 Market Forecast by Region, 2026-2036 (US$ Billion, AGR %)
- 4.4.2 Market Share by Region, 2026 & 2036 (%)
- 4.5 Generics
- 4.5.1 Market Forecast by Region, 2026-2036 (US$ Billion, AGR %)
- 4.5.2 Market Share by Region, 2026 & 2036 (%)
5 Pharmaceutical Contract Manufacturing Market Analysis by Services
- 5.1 Key Findings
- 5.2 Services Segment: Market Attractiveness Index
- 5.3 Pharmaceutical Contract Manufacturing Market Size Estimation and Forecast by Services
- 5.4 Pharmaceutical Manufacturing Services
- 5.4.1 Market Forecast by Region, 2026-2036 (US$ Billion, AGR %)
- 5.4.2 Market Share by Region, 2026 & 2036 (%)
- 5.4.3 Pharmaceutical Manufacturing Services Market Forecast by Type, 2026-2036 (US$ Billion, AGR %)
- 5.4.4 Pharmaceutical API Manufacturing Services
- 5.4.5 Pharmaceutical FDF Manufacturing Services
- 5.5 Drug Development Services
- 5.5.1 Market Forecast by Region, 2026-2036 (US$ Billion, AGR %)
- 5.5.2 Market Share by Region, 2026 & 2036 (%)
- 5.5.3 Drug Development Services Market Forecast by Type, 2026-2036 (US$ Billion, AGR %)
- 5.5.4 Lead Identification and Candidate Optimization
- 5.5.5 Target Identification and Screening
- 5.5.6 Target Validation and Functional Informatics
- 5.5.7 Other Services
- 5.6 Biologics Manufacturing Services
- 5.6.1 Market Forecast by Region, 2026-2036 (US$ Billion, AGR %)
- 5.6.2 Market Share by Region, 2026 & 2036 (%)
- 5.6.3 Biologics Manufacturing Services Market Forecast by Type, 2026-2036 (US$ Billion, AGR %)
- 5.6.4 Biologics API Manufacturing Services
- 5.6.5 Biologics FDF Manufacturing Services
6 Pharmaceutical Contract Manufacturing Market Analysis by Scale of Operation
- 6.1 Key Findings
- 6.2 Scale of Operation Segment: Market Attractiveness Index
- 6.3 Pharmaceutical Contract Manufacturing Market Size Estimation and Forecast by Scale of Operation
- 6.4 Clinical
- 6.4.1 Market Forecast by Region, 2026-2036 (US$ Billion, AGR %)
- 6.4.2 Market Share by Region, 2026 & 2036 (%)
- 6.5 Commercial
- 6.5.1 Market Forecast by Region, 2026-2036 (US$ Billion, AGR %)
- 6.5.2 Market Share by Region, 2026 & 2036 (%)
7 Pharmaceutical Contract Manufacturing Market Analysis by End-users
- 7.1 Key Findings
- 7.2 End-users Segment: Market Attractiveness Index
- 7.3 Pharmaceutical Contract Manufacturing Market Size Estimation and Forecast by End-users
- 7.4 Big Pharmaceutical Companies
- 7.4.1 Market Forecast by Region, 2026-2036 (US$ Billion, AGR %)
- 7.4.2 Market Share by Region, 2026 & 2036 (%)
- 7.5 Small & Medium-sized Pharmaceutical Companies
- 7.5.1 Market Forecast by Region, 2026-2036 (US$ Billion, AGR %)
- 7.5.2 Market Share by Region, 2026 & 2036 (%)
- 7.6 Generic Pharmaceutical Companies
- 7.6.1 Market Forecast by Region, 2026-2036 (US$ Billion, AGR %)
- 7.6.2 Market Share by Region, 2026 & 2036 (%)
- 7.7 Others
- 7.7.1 Market Forecast by Region, 2026-2036 (US$ Billion, AGR %)
- 7.7.2 Market Share by Region, 2026 & 2036 (%)
8 Pharmaceutical Contract Manufacturing Market Analysis by Region
- 8.1 Key Findings
- 8.2 Regional Market Size Estimation and Forecast
9 North America Pharmaceutical Contract Manufacturing Market Analysis
- 9.1 Key Findings
- 9.2 North America Pharmaceutical Contract Manufacturing Market Attractiveness Index
- 9.3 North America Pharmaceutical Contract Manufacturing Market by Country, 2026, 2031 & 2036 (US$ Billion)
- 9.4 North America Pharmaceutical Contract Manufacturing Market Size Estimation and Forecast by Country
- 9.5 North America Pharmaceutical Contract Manufacturing Market Size Estimation and Forecast by Drug Type
- 9.6 North America Pharmaceutical Contract Manufacturing Market Size Estimation and Forecast by Services
- 9.7 North America Pharmaceutical Contract Manufacturing Market Size Estimation and Forecast by Scale of Operation
- 9.8 North America Pharmaceutical Contract Manufacturing Market Size Estimation and Forecast by End-users
- 9.9 U.S. Pharmaceutical Contract Manufacturing Market Analysis
- 9.10 Canada Pharmaceutical Contract Manufacturing Market Analysis
10 Europe Pharmaceutical Contract Manufacturing Market Analysis
- 10.1 Key Findings
- 10.2 Europe Pharmaceutical Contract Manufacturing Market Attractiveness Index
- 10.3 Europe Pharmaceutical Contract Manufacturing Market by Country, 2026, 2031 & 2036 (US$ Billion)
- 10.4 Europe Pharmaceutical Contract Manufacturing Market Size Estimation and Forecast by Country
- 10.5 Europe Pharmaceutical Contract Manufacturing Market Size Estimation and Forecast by Drug Type
- 10.6 Europe Pharmaceutical Contract Manufacturing Market Size Estimation and Forecast by Services
- 10.7 Europe Pharmaceutical Contract Manufacturing Market Size Estimation and Forecast by Scale of Operation
- 10.8 Europe Pharmaceutical Contract Manufacturing Market Size Estimation and Forecast by End-users
- 10.9 Germany Pharmaceutical Contract Manufacturing Market Analysis
- 10.10 UK Pharmaceutical Contract Manufacturing Market Analysis
- 10.11 France Pharmaceutical Contract Manufacturing Market Analysis
- 10.12 Italy Pharmaceutical Contract Manufacturing Market Analysis
- 10.13 Spain Pharmaceutical Contract Manufacturing Market Analysis
- 10.14 Rest of Europe Pharmaceutical Contract Manufacturing Market Analysis
11 Asia Pacific Pharmaceutical Contract Manufacturing Market Analysis
- 11.1 Key Findings
- 11.2 Asia Pacific Pharmaceutical Contract Manufacturing Market Attractiveness Index
- 11.3 Asia Pacific Pharmaceutical Contract Manufacturing Market by Country, 2026, 2031 & 2036 (US$ Billion)
- 11.4 Asia Pacific Pharmaceutical Contract Manufacturing Market Size Estimation and Forecast by Country
- 11.5 Asia Pacific Pharmaceutical Contract Manufacturing Market Size Estimation and Forecast by Drug Type
- 11.6 Asia Pacific Pharmaceutical Contract Manufacturing Market Size Estimation and Forecast by Services
- 11.7 Asia Pacific Pharmaceutical Contract Manufacturing Market Size Estimation and Forecast by Scale of Operation
- 11.8 Asia Pacific Pharmaceutical Contract Manufacturing Market Size Estimation and Forecast by End-users
- 11.9 Japan Pharmaceutical Contract Manufacturing Market Analysis
- 11.10 China Pharmaceutical Contract Manufacturing Market Analysis
- 11.11 India Pharmaceutical Contract Manufacturing Market Analysis
- 11.12 Australia Pharmaceutical Contract Manufacturing Market Analysis
- 11.13 Rest of Asia Pacific Pharmaceutical Contract Manufacturing Market Analysis
12 Latin America Pharmaceutical Contract Manufacturing Market Analysis
- 12.1 Key Findings
- 12.2 Latin America Pharmaceutical Contract Manufacturing Market Attractiveness Index
- 12.3 Latin America Pharmaceutical Contract Manufacturing Market by Country, 2026, 2031 & 2036 (US$ Billion)
- 12.4 Latin America Pharmaceutical Contract Manufacturing Market Size Estimation and Forecast by Country
- 12.5 Latin America Pharmaceutical Contract Manufacturing Market Size Estimation and Forecast by Drug Type
- 12.6 Latin America Pharmaceutical Contract Manufacturing Market Size Estimation and Forecast by Services
- 12.7 Latin America Pharmaceutical Contract Manufacturing Market Size Estimation and Forecast by Scale of Operation
- 12.8 Latin America Pharmaceutical Contract Manufacturing Market Size Estimation and Forecast by End-users
- 12.9 Brazil Pharmaceutical Contract Manufacturing Market Analysis
- 12.10 Mexico Pharmaceutical Contract Manufacturing Market Analysis
- 12.11 Rest of Latin America Pharmaceutical Contract Manufacturing Market Analysis
13 MEA Pharmaceutical Contract Manufacturing Market Analysis
- 13.1 Key Findings
- 13.2 MEA Pharmaceutical Contract Manufacturing Market Attractiveness Index
- 13.3 MEA Pharmaceutical Contract Manufacturing Market by Country, 2026, 2031 & 2036 (US$ Billion)
- 13.4 MEA Pharmaceutical Contract Manufacturing Market Size Estimation and Forecast by Country
- 13.5 MEA Pharmaceutical Contract Manufacturing Market Size Estimation and Forecast by Drug Type
- 13.6 MEA Pharmaceutical Contract Manufacturing Market Size Estimation and Forecast by Services
- 13.7 MEA Pharmaceutical Contract Manufacturing Market Size Estimation and Forecast by Scale of Operation
- 13.8 MEA Pharmaceutical Contract Manufacturing Market Size Estimation and Forecast by End-users
- 13.9 GCC Pharmaceutical Contract Manufacturing Market Analysis
- 13.10 South Africa Pharmaceutical Contract Manufacturing Market Analysis
- 13.11 Rest of MEA Pharmaceutical Contract Manufacturing Market Analysis
14 Company Profiles
- 14.1 Competitive Landscape
- 14.2 Strategic Outlook
- 14.3 Lonza
- 14.3.1 Company Snapshot
- 14.3.2 Company Overview
- 14.3.3 Financial Analysis
- 14.3.3.1 Net Revenue, 2021-2025
- 14.3.3.2 R&D, 2021-2025
- 14.3.3.3 Regional Market Shares, 2025
- 14.3.3.4 Business Segment Market Shares, 2025
- 14.3.4 Service Benchmarking
- 14.3.5 Strategic Outlook
- 14.4 Catalent, Inc. (A Novo Holdings Company)
- 14.4.1 Company Snapshot
- 14.4.2 Company Overview
- 14.4.3 Financial Analysis
- 14.4.3.1 Net Revenue, 2021-2024
- 14.4.3.2 Regional Market Shares, 2024
- 14.4.3.3 Business Segment Market Shares, 2024
- 14.4.4 Service Benchmarking
- 14.4.5 Strategic Outlook
- 14.5 Recipharm AB
- 14.5.1 Company Snapshot
- 14.5.2 Company Overview
- 14.5.3 Service Benchmarking
- 14.5.4 Strategic Outlook
- 14.6 AbbVie Inc.
- 14.6.1 Company Snapshot
- 14.6.2 Company Overview
- 14.6.3 Financial Analysis
- 14.6.3.1 Net Revenue, 2021-2025
- 14.6.3.2 R&D, 2021-2025
- 14.6.3.3 Regional Market Shares, 2025
- 14.6.3.4 Business Segment Market Shares, 2025
- 14.6.4 Service Benchmarking
- 14.7 Thermo Fisher Scientific Inc.
- 14.7.1 Company Snapshot
- 14.7.2 Company Overview
- 14.7.3 Financial Analysis
- 14.7.3.1 Net Revenue, 2021-2025
- 14.7.3.2 R&D, 2021-2025
- 14.7.3.3 Regional Market Shares, 2025
- 14.7.3.4 Business Segment Market Shares, 2025
- 14.7.4 Service Benchmarking
- 14.7.5 Strategic Outlook
- 14.8 Siegfried Holding AG
- 14.8.1 Company Snapshot
- 14.8.2 Company Overview
- 14.8.3 Financial Analysis
- 14.8.3.1 Net Revenue, 2021-2025
- 14.8.3.2 Regional Market Shares, 2025
- 14.8.3.3 Business Segment Market Shares, 2025
- 14.8.4 Service Benchmarking
- 14.8.5 Strategic Outlook
- 14.9 Evonik Industries AG
- 14.9.1 Company Snapshot
- 14.9.2 Company Overview
- 14.9.3 Financial Analysis
- 14.9.3.1 Net Revenue, 2021-2025
- 14.9.3.2 Regional Market Shares, 2025
- 14.9.3.3 Business Segment Market Shares, 2025
- 14.9.4 Service Benchmarking
- 14.9.5 Strategic Outlook
- 14.10 Boehringer Ingelheim International GmbH
- 14.10.1 Company Snapshot
- 14.10.2 Company Overview
- 14.10.3 Financial Analysis
- 14.10.3.1 Net Revenue, 2021-2025
- 14.10.3.2 R&D, 2021-2025
- 14.10.3.3 Regional Market Shares, 2025
- 14.10.3.4 Business Segment Market Shares, 2025
- 14.10.4 Service Benchmarking
- 14.11 Piramal Pharma Solutions
- 14.11.1 Company Snapshot
- 14.11.2 Company Overview
- 14.11.3 Financial Analysis
- 14.11.3.1 Net Revenue, 2021-2025
- 14.11.3.2 Business Segment Market Shares, 2025
- 14.11.4 Service Benchmarking
- 14.11.5 Strategic Outlook
- 14.12 Samsung Biologics
- 14.12.1 Company Snapshot
- 14.12.2 Company Overview
- 14.12.3 Financial Analysis
- 14.12.3.1 Net Revenue, 2021-2025
- 14.12.4 Service Benchmarking
- 14.12.5 Strategic Outlook
- 14.13 WuXi AppTec
- 14.13.1 Company Snapshot
- 14.13.2 Company Overview
- 14.13.3 Financial Analysis
- 14.13.3.1 Net Revenue, 2021-2025
- 14.13.3.2 Regional Market Shares, 2025
- 14.13.3.3 Business Segment Market Shares, 2025
- 14.13.4 Service Benchmarking
- 14.13.5 Strategic Outlook
- 14.14 FUJIFILM Diosynth Biotechnologies
- 14.14.1 Company Snapshot
- 14.14.2 Company Overview
- 14.14.3 Financial Analysis
- 14.14.3.1 Net Revenue, 2021-2024
- 14.14.3.2 R&D, 2021-2024
- 14.14.4 Service Benchmarking
- 14.14.5 Strategic Outlook
- 14.15 ICON plc
- 14.15.1 Company Snapshot
- 14.15.2 Company Overview
- 14.15.3 Financial Analysis
- 14.15.3.1 Net Revenue, 2021-2024
- 14.15.3.2 Regional Market Shares, 2024
- 14.15.4 Service Benchmarking
- 14.15.5 Strategic Outlook
- 14.16 Abnova Corporation
- 14.16.1 Company Snapshot
- 14.16.2 Company Overview
- 14.16.3 Service Benchmarking
- 14.16.4 Strategic Outlook
- 14.17 Vetter Pharma
- 14.17.1 Company Snapshot
- 14.17.2 Company Overview
- 14.17.3 Service Benchmarking
- 14.17.4 Strategic Outlook
- 14.18 Aenova Group
- 14.18.1 Company Snapshot
- 14.18.2 Company Overview
- 14.18.3 Financial Analysis
- 14.18.3.1 Net Revenue, 2021-2024
- 14.18.3.2 Regional Market Shares, 2024
- 14.18.3.3 Business Segment Market Shares, 2024
- 14.18.4 Service Benchmarking
- 14.18.5 Strategic Outlook
- 14.19 Almac Group
- 14.19.1 Company Snapshot
- 14.19.2 Company Overview
- 14.19.3 Service Benchmarking
- 14.19.4 Strategic Outlook
- 14.20 Nipro Pharma Corporation
- 14.20.1 Company Snapshot
- 14.20.2 Company Overview
- 14.20.3 Financial Analysis
- 14.20.3.1 Net Revenue, 2021-2025
- 14.20.3.2 R&D, 2021-2025
- 14.20.3.3 Regional Market Shares, 2025
- 14.20.3.4 Business Segment Market Shares, 2025
- 14.20.4 Service Benchmarking
- 14.20.5 Strategic Outlook
- 14.21 Jubilant Pharmova Limited
- 14.21.1 Company Snapshot
- 14.21.2 Company Overview
- 14.21.3 Service Benchmarking
- 14.21.4 Strategic Outlook
- 14.22 Pfizer Inc.
- 14.22.1 Company Snapshot
- 14.22.2 Company Overview
- 14.22.3 Financial Analysis
- 14.22.3.1 Net Revenue, 2021-2025
- 14.22.3.2 R&D, 2021-2025
- 14.22.3.3 Regional Market Shares, 2025
- 14.22.3.4 Business Segment Market Shares, 2025
- 14.22.4 Service Benchmarking
- 14.23 Grifols, S.A.
- 14.23.1 Company Snapshot
- 14.23.2 Company Overview
- 14.23.3 Financial Analysis
- 14.23.3.1 Net Revenue, 2021-2025
- 14.23.3.2 R&D, 2021-2025
- 14.23.4 Strategic Outlook
- 14.24 Charles River Laboratories
- 14.24.1 Company Snapshot
- 14.24.2 Company Overview
- 14.24.3 Financial Analysis
- 14.24.3.1 Net Revenue, 2021-2025
- 14.24.3.2 Regional Market Shares, 2025
- 14.24.3.3 Business Segment Market Shares, 2025
- 14.24.4 Service Benchmarking
- 14.24.5 Strategic Outlook
- 14.25 IQVIA Inc.
- 14.25.1 Company Snapshot
- 14.25.2 Company Overview
- 14.25.3 Financial Analysis
- 14.25.3.1 Net Revenue, 2021-2025
- 14.25.3.2 Regional Market Shares, 2025
- 14.25.3.3 Business Segment Market Shares, 2025
- 14.25.4 Service Benchmarking
- 14.26 Baxter
- 14.26.1 Company Snapshot
- 14.26.2 Company Overview
- 14.26.3 Financial Analysis
- 14.26.3.1 Net Revenue, 2021-2025
- 14.26.3.2 R&D, 2021-2025
- 14.26.3.3 Regional Market Shares, 2025
- 14.26.3.4 Business Segment Market Shares, 2025
- 14.26.4 Service Benchmarking
- 14.27 Curia Global, Inc.
- 14.27.1 Company Snapshot
- 14.27.2 Company Overview
- 14.27.3 Service Benchmarking
- 14.27.4 Strategic Outlook
- 14.28 Lannett
- 14.28.1 Company Snapshot
- 14.28.2 Company Overview
- 14.28.3 Service Benchmarking
- 14.29 Eurofins Scientific
- 14.29.1 Company Snapshot
- 14.29.2 Company Overview
- 14.29.3 Financial Analysis
- 14.29.3.1 Net Revenue, 2021-2025
- 14.29.3.2 Regional Market Shares, 2025
- 14.29.3.3 Business Segment Market Shares, 2025
- 14.29.4 Service Benchmarking
- 14.30 IDT Biologika
- 14.30.1 Company Snapshot
- 14.30.2 Company Overview
- 14.30.3 Service Benchmarking
- 14.30.4 Strategic Outlook
- 14.31 Cambrex Corporation
- 14.31.1 Company Snapshot
- 14.31.2 Company Overview
- 14.31.3 Service Benchmarking
- 14.31.4 Strategic Outlook
15 Conclusion and Recommendations
- 15.1 Concluding Remarks from Visiongain
- 15.2 Recommendations for Market Players
Product Code: PHA1388
List of Tables
- Table 1 Pharmaceutical Contract Manufacturing Market Snapshot, 2026 & 2036 (US$ Billion, CAGR %)
- Table 2 Patent Expiry, 2025-2026
- Table 3 Pharmaceutical Contract Manufacturing Market Forecast by Region, 2026-2036 (US$ Billion, AGR%, CAGR%): "V" Shaped Recovery
- Table 4 Pharmaceutical Contract Manufacturing Market Forecast by Region, 2026-2036 (US$ Billion, AGR%, CAGR%): "U" Shaped Recovery
- Table 5 Pharmaceutical Contract Manufacturing Market Forecast by Region, 2026-2036 (US$ Billion, AGR%, CAGR%): "L" Shaped Recovery
- Table 6 Pharmaceutical Contract Manufacturing Market Forecast by Drug Type, 2026-2036 (US$ Billion, AGR%, CAGR%)
- Table 7 Branded Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR%, CAGR%)
- Table 8 Generics Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR%, CAGR%)
- Table 9 Pharmaceutical Contract Manufacturing Market Forecast by Services, 2026-2036 (US$ Billion, AGR %, CAGR %)
- Table 10 Pharmaceutical Manufacturing Services Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR%, CAGR%)
- Table 11 Pharmaceutical Contract Manufacturing Market Forecast by Pharmaceutical Manufacturing Services, 2026-2036 (US$ Billion, AGR %, CAGR %)
- Table 12 Drug Development Services Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR%, CAGR%)
- Table 13 Pharmaceutical Contract Manufacturing Market Forecast by End-users, 2026-2036 (US$ Billion, AGR %, CAGR %)
- Table 14 Biologics Manufacturing Services Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR%, CAGR%)
- Table 15 Pharmaceutical Contract Manufacturing Market Forecast by Pharmaceutical Manufacturing Services, 2026-2036 (US$ Billion, AGR %, CAGR %)
- Table 16 Pharmaceutical Contract Manufacturing Market Forecast by Scale of Operation, 2026-2036 (US$ Billion, AGR%, CAGR%)
- Table 17 Clinical Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR%, CAGR%)
- Table 18 Commercial Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR%, CAGR%)
- Table 19 Pharmaceutical Contract Manufacturing Market Forecast by End-users, 2026-2036 (US$ Billion, AGR%, CAGR%)
- Table 20 Big Pharmaceutical Companies Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR%, CAGR%)
- Table 21 Small & Medium-sized Pharmaceutical Companies Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR%, CAGR%)
- Table 22 Generic Pharmaceutical Companies Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR%, CAGR%)
- Table 23 Others Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR%, CAGR%)
- Table 24 Pharmaceutical Contract Manufacturing Market Forecast by Region, 2026-2036 (US$ Billion, AGR%, CAGR%)
- Table 25 North America Pharmaceutical Contract Manufacturing Market Forecast by Country, 2026-2036 (US$ Billion, AGR%, CAGR%)
- Table 26 North America Pharmaceutical Contract Manufacturing Market Forecast by Drug Type, 2026-2036 (US$ Billion, AGR%, CAGR%)
- Table 27 North America Pharmaceutical Contract Manufacturing Market Forecast by Services, 2026-2036 (US$ Billion, AGR%, CAGR%)
- Table 28 North America Pharmaceutical Contract Manufacturing Market Forecast by Scale of Operation, 2026-2036 (US$ Billion, AGR%, CAGR%)
- Table 29 North America Pharmaceutical Contract Manufacturing Market Forecast by End-users, 2026-2036 (US$ Billion, AGR%, CAGR%)
- Table 30 U.S. Pharmaceutical Contract Manufacturing Market Forecast, 2026-2036 (US$ Bn, AGR%, CAGR%)
- Table 31 Canada Pharmaceutical Contract Manufacturing Market Forecast, 2026-2036 (US$ Bn, AGR%, CAGR%)
- Table 32 Europe Pharmaceutical Contract Manufacturing Market Forecast by Country, 2026-2036 (US$ Billion, AGR%, CAGR%)
- Table 33 Europe Pharmaceutical Contract Manufacturing Market Forecast by Drug Type, 2026-2036 (US$ Billion, AGR%, CAGR%)
- Table 34 Europe Pharmaceutical Contract Manufacturing Market Forecast by Services, 2026-2036 (US$ Billion, AGR%, CAGR%)
- Table 35 Europe Pharmaceutical Contract Manufacturing Market Forecast by Scale of Operation, 2026-2036 (US$ Billion, AGR%, CAGR%)
- Table 36 Europe Pharmaceutical Contract Manufacturing Market Forecast by End-users, 2026-2036 (US$ Billion, AGR%, CAGR%)
- Table 37 Germany Pharmaceutical Contract Manufacturing Market Forecast, 2026-2036 (US$ Bn, AGR%, CAGR%)
- Table 38 UK Pharmaceutical Contract Manufacturing Market Forecast, 2026-2036 (US$ Bn, AGR%, CAGR%)
- Table 39 France Pharmaceutical Contract Manufacturing Market Forecast, 2026-2036 (US$ Bn, AGR%, CAGR%)
- Table 40 Italy Pharmaceutical Contract Manufacturing Market Forecast, 2026-2036 (US$ Bn, AGR%, CAGR%)
- Table 41 Spain Pharmaceutical Contract Manufacturing Market Forecast, 2026-2036 (US$ Bn, AGR%, CAGR%)
- Table 42 Rest of Europe Pharmaceutical Contract Manufacturing Market Forecast, 2026-2036 (US$ Bn, AGR%, CAGR%)
- Table 43 Asia Pacific Pharmaceutical Contract Manufacturing Market Forecast by Country, 2026-2036 (US$ Billion, AGR%, CAGR%)
- Table 44 Asia Pacific Pharmaceutical Contract Manufacturing Market Forecast by Drug Type, 2026-2036 (US$ Billion, AGR%, CAGR%)
- Table 45 Asia Pacific Pharmaceutical Contract Manufacturing Market Forecast by Services, 2026-2036 (US$ Billion, AGR%, CAGR%)
- Table 46 Asia Pacific Pharmaceutical Contract Manufacturing Market Forecast by Scale of Operation, 2026-2036 (US$ Billion, AGR%, CAGR%)
- Table 47 Asia Pacific Pharmaceutical Contract Manufacturing Market Forecast by End-users, 2026-2036 (US$ Billion, AGR%, CAGR%)
- Table 48 Japan Pharmaceutical Contract Manufacturing Market Forecast, 2026-2036 (US$ Bn, AGR%, CAGR%)
- Table 49 China Pharmaceutical Contract Manufacturing Market Forecast, 2026-2036 (US$ Bn, AGR%, CAGR%)
- Table 50 India Pharmaceutical Contract Manufacturing Market Forecast, 2026-2036 (US$ Bn, AGR%, CAGR%)
- Table 51 Australia Pharmaceutical Contract Manufacturing Market Forecast, 2026-2036 (US$ Bn, AGR%, CAGR%)
- Table 52 Rest of Asia Pacific Pharmaceutical Contract Manufacturing Market Forecast, 2026-2036 (US$ Bn, AGR%, CAGR%)
- Table 53 Latin America Pharmaceutical Contract Manufacturing Market Forecast by Country, 2026-2036 (US$ Billion, AGR%, CAGR%)
- Table 54 Latin America Pharmaceutical Contract Manufacturing Market Forecast by Services, 2026-2036 (US$ Billion, AGR%, CAGR%)
- Table 55 Latin America Pharmaceutical Contract Manufacturing Market Forecast by Scale of Operation, 2026-2036 (US$ Billion, AGR%, CAGR%)
- Table 56 Latin America Pharmaceutical Contract Manufacturing Market Forecast by End-users, 2026-2036 (US$ Billion, AGR%, CAGR%)
- Table 57 Brazil Pharmaceutical Contract Manufacturing Market Forecast, 2026-2036 (US$ Bn, AGR%, CAGR%)
- Table 58 Mexico Pharmaceutical Contract Manufacturing Market Forecast, 2026-2036 (US$ Bn, AGR%, CAGR%)
- Table 59 Rest of Latin America Pharmaceutical Contract Manufacturing Market Forecast, 2026-2036 (US$ Bn, AGR%, CAGR%)
- Table 60 MEA Pharmaceutical Contract Manufacturing Market Forecast by Country, 2026-2036 (US$ Billion, AGR%, CAGR%)
- Table 61 MEA Pharmaceutical Contract Manufacturing Market Forecast by Drug Type, 2026-2036 (US$ Billion, AGR%, CAGR%)
- Table 62 MEA Pharmaceutical Contract Manufacturing Market Forecast by Services, 2026-2036 (US$ Billion, AGR%, CAGR%)
- Table 63 MEA Pharmaceutical Contract Manufacturing Market Forecast by Scale of Operation, 2026-2036 (US$ Billion, AGR%, CAGR%)
- Table 64 MEA Pharmaceutical Contract Manufacturing Market Forecast by End-users, 2026-2036 (US$ Billion, AGR%, CAGR%)
- Table 65 GCC Pharmaceutical Contract Manufacturing Market Forecast, 2026-2036 (US$ Bn, AGR%, CAGR%)
- Table 66 South Africa Pharmaceutical Contract Manufacturing Market Forecast, 2026-2036 (US$ Bn, AGR%, CAGR%)
- Table 67 Rest of MEA Pharmaceutical Contract Manufacturing Market Forecast, 2026-2036 (US$ Bn, AGR%, CAGR%)
- Table 68 Company Ranking
- Table 69 Strategic Outlook
- Table 70 Lonza: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
- Table 71 Lonza: Service Benchmarking
- Table 72 Lonza: Strategic Outlook
- Table 73 Catalent, Inc. (A Novo Holdings Company): Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
- Table 74 Catalent, Inc. (A Novo Holdings Company): Service Benchmarking
- Table 75 Catalent, Inc. (A Novo Holdings Company): Strategic Outlook
- Table 76 Recipharm AB: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
- Table 77 Recipharm AB: Service Benchmarking
- Table 78 Recipharm AB: Strategic Outlook
- Table 79 AbbVie Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
- Table 80 AbbVie Inc.: Service Benchmarking
- Table 81 Thermo Fisher Scientific Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
- Table 82 Thermo Fisher Scientific Inc.: Service Benchmarking
- Table 83 Thermo Fisher Scientific Inc.: Strategic Outlook
- Table 84 Siegfried Holding AG: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
- Table 85 Siegfried Holding AG: Service Benchmarking
- Table 86 Siegfried Holding AG: Strategic Outlook
- Table 87 Evonik Industries AG: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
- Table 88 Evonik Industries AG: Service Benchmarking
- Table 89 Evonik Industries AG: Strategic Outlook
- Table 90 Boehringer Ingelheim International GmbH: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
- Table 91 Boehringer Ingelheim International GmbH: Service Benchmarking
- Table 92 Piramal Pharma Solutions: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
- Table 93 Piramal Pharma Solutions: Service Benchmarking
- Table 94 Piramal Pharma Solutions: Strategic Outlook
- Table 95 Samsung Biologics: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
- Table 96 Samsung Biologics: Service Benchmarking
- Table 97 Samsung Biologics: Strategic Outlook
- Table 98 WuXi AppTec: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
- Table 99 WuXi AppTec: Service Benchmarking
- Table 100 WuXi AppTec: Strategic Outlook
- Table 101 FUJIFILM Diosynth Biotechnologies: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
- Table 102 FUJIFILM Diosynth Biotechnologies: Service Benchmarking
- Table 103 FUJIFILM Diosynth Biotechnologies: Strategic Outlook
- Table 104 ICON plc: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
- Table 105 ICON plc: Service Benchmarking
- Table 106 ICON plc: Strategic Outlook
- Table 107 Abnova Corporation: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
- Table 108 Abnova Corporation: Service Benchmarking
- Table 109 Abnova Corporation: Strategic Outlook
- Table 110 Vetter Pharma: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
- Table 111 Vetter Pharma: Service Benchmarking
- Table 112 Vetter Pharma: Strategic Outlook
- Table 113 Aenova Group: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
- Table 114 Aenova Group: Service Benchmarking
- Table 115 Aenova Group: Strategic Outlook
- Table 116 Almac Group: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
- Table 117 Almac Group: Service Benchmarking
- Table 118 Almac Group: Strategic Outlook
- Table 119 Nipro Pharma Corporation: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
- Table 120 Nipro Pharma Corporation: Service Benchmarking
- Table 121 Nipro Pharma Corporation: Strategic Outlook
- Table 122 Jubilant Pharmova Limited: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
- Table 123 Jubilant Pharmova Limited: Service Benchmarking
- Table 124 Jubilant Pharmova Limited: Strategic Outlook
- Table 125 Pfizer Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
- Table 126 Pfizer Inc.: Service Benchmarking
- Table 127 Grifols, S.A.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
- Table 128 Grifols, S.A.: Strategic Outlook
- Table 129 Charles River Laboratories: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
- Table 130 Charles River Laboratories: Service Benchmarking
- Table 131 Charles River Laboratories: Strategic Outlook
- Table 132 IQVIA Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
- Table 133 IQVIA Inc.: Service Benchmarking
- Table 134 Baxter: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
- Table 135 Baxter: Service Benchmarking
- Table 136 Curia Global, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
- Table 137 Curia Global, Inc.: Service Benchmarking
- Table 138 Curia Global, Inc.: Strategic Outlook
- Table 139 Lannett: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
- Table 140 Lannett: Service Benchmarking
- Table 141 Eurofins Scientific: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
- Table 142 Eurofins Scientific: Service Benchmarking
- Table 143 IDT Biologika: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
- Table 144 IDT Biologika: Service Benchmarking
- Table 145 IDT Biologika: Strategic Outlook
- Table 146 Cambrex Corporation: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
- Table 147 Cambrex Corporation: Service Benchmarking
- Table 148 Cambrex Corporation: Strategic Outlook
List of Figures
- Figure 1 Pharmaceutical Contract Manufacturing Market Segmentation
- Figure 2 Pharmaceutical Contract Manufacturing Market by Drug Type: Market Attractiveness Index
- Figure 3 Pharmaceutical Contract Manufacturing Market by Services: Market Attractiveness Index
- Figure 4 Pharmaceutical Contract Manufacturing Market by Scale of Operation: Market Attractiveness Index
- Figure 5 Pharmaceutical Contract Manufacturing Market by End-users: Market Attractiveness Index
- Figure 6 Pharmaceutical Contract Manufacturing Market Attractiveness Index by Region
- Figure 7 Pharmaceutical Contract Manufacturing Market: Market Dynamics
- Figure 8 Pharmaceutical Contract Manufacturing Market: Impact Analysis
- Figure 9 R&D Expenditure of Major Companies, 2024 & 2025 (US$ Billion)
- Figure 10 CDER's Novel Drug Approvals by Year
- Figure 11 Pharmaceutical Contract Manufacturing Market: Porter's Five Forces Analysis
- Figure 12 Pharmaceutical Contract Manufacturing Market: PEST Analysis
- Figure 13 Pharmaceutical Contract Manufacturing Market by Region, 2026-2036 (US$ Million, AGR %), Tariff Impact: V-Shaped Recovery Scenario
- Figure 14 Pharmaceutical Contract Manufacturing Market by Region, 2026-2036 (US$ Billion, AGR %), Tariff Impact: U-Shaped Recovery Scenario
- Figure 15 Pharmaceutical Contract Manufacturing Market by Region, 2026-2036 (US$ Billion, AGR %), Tariff Impact: L-Shaped Recovery Scenario
- Figure 16 Short Term & Long-Term Planning
- Figure 17 Impact of U.S. and China Trade War
- Figure 18 Most Impacted Countries
- Figure 19 Pharmaceutical Contract Manufacturing Market Attractiveness Index by Drug Type
- Figure 20 Pharmaceutical Contract Manufacturing Market Forecast by Drug Type, 2026-2036 (US$ Billion, AGR %)
- Figure 21 Pharmaceutical Contract Manufacturing Market Share Forecast by Drug Type, 2026, 2031, 2036 (%)
- Figure 22 Branded Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR %)
- Figure 23 Branded Segment Market Share Forecast by Region, 2026 & 2036 (%)
- Figure 24 Generics Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR %)
- Figure 25 Generics Segment Market Share Forecast by Region, 2026 & 2036 (%)
- Figure 26 Pharmaceutical Contract Manufacturing Market Attractiveness Index by Drug Type
- Figure 27 Pharmaceutical Contract Manufacturing Market Forecast by Services, 2026-2036 (US$ Billion, AGR %)
- Figure 28 Pharmaceutical Contract Manufacturing Market Share Forecast by Services, 2026, 2031, 2036 (%)
- Figure 29 Pharmaceutical Manufacturing Services Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR %)
- Figure 30 Pharmaceutical Manufacturing Services Segment Market Share Forecast by Region, 2026 & 2036 (%)
- Figure 31 Pharmaceutical Manufacturing Services Segment Market Forecast by Type, 2026-2036 (US$ Billion, AGR %)
- Figure 32 Drug Development Services Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR %)
- Figure 33 Drug Development Services Segment Market Share Forecast by Region, 2026 & 2036 (%)
- Figure 34 Drug Development Services Segment Market Forecast by Type, 2026-2036 (US$ Billion, AGR %)
- Figure 35 Biologics Manufacturing Services Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR %)
- Figure 36 Biologics Manufacturing Services Segment Market Share Forecast by Region, 2026 & 2036 (%)
- Figure 37 Pharmaceutical Manufacturing Services Segment Market Forecast by Type, 2026-2036 (US$ Billion, AGR %)
- Figure 38 Pharmaceutical Contract Manufacturing Market Attractiveness Index by Scale of Operation
- Figure 39 Pharmaceutical Contract Manufacturing Market Forecast by Scale of Operation, 2026-2036 (US$ Billion, AGR %)
- Figure 40 Pharmaceutical Contract Manufacturing Market Share Forecast by Scale of Operation, 2026, 2031, 2036 (%)
- Figure 41 Clinical Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR %)
- Figure 42 Clinical Segment Market Share Forecast by Region, 2026 & 2036 (%)
- Figure 43 Commercial Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR %)
- Figure 44 Commercial Segment Market Share Forecast by Region, 2026 & 2036 (%)
- Figure 45 Pharmaceutical Contract Manufacturing Market Attractiveness Index by End-users
- Figure 46 Pharmaceutical Contract Manufacturing Market Forecast by End-users, 2026-2036 (US$ Billion, AGR %)
- Figure 47 Pharmaceutical Contract Manufacturing Market Share Forecast by End-users, 2026, 2031, 2036 (%)
- Figure 48 Big Pharmaceutical Companies Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR %)
- Figure 49 Big Pharmaceutical Companies Segment Market Share Forecast by Region, 2026 & 2036 (%)
- Figure 50 Small & Medium-sized Pharmaceutical Companies Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR %)
- Figure 51 Small & Medium-sized Pharmaceutical Companies Segment Market Share Forecast by Region, 2026 & 2036 (%)
- Figure 52 Generic Pharmaceutical Companies Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR %)
- Figure 53 Generic Pharmaceutical Companies Segment Market Share Forecast by Region, 2026 & 2036 (%)
- Figure 54 Others Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR %)
- Figure 55 Others Segment Market Share Forecast by Region, 2026 & 2036 (%)
- Figure 56 Pharmaceutical Contract Manufacturing Market Forecast by Region 2026, 2031, 2036 (Revenue, CAGR%)
- Figure 57 Pharmaceutical Contract Manufacturing Market Share Forecast by Region 2026, 2031, 2036 (%)
- Figure 58 Pharmaceutical Contract Manufacturing Market by Region, 2026-2036 (US$ Bn, AGR %)
- Figure 59 North America Pharmaceutical Contract Manufacturing Market Attractiveness Index
- Figure 60 North America Pharmaceutical Contract Manufacturing Market by Region, 2026, 2031 & 2036 (US$ Billion)
- Figure 61 North America Pharmaceutical Contract Manufacturing Market Forecast by Country, 2026-2036 (US$ Billion, AGR %)
- Figure 62 North America Pharmaceutical Contract Manufacturing Market Share Forecast by Country, 2026 & 2036 (%)
- Figure 63 North America Pharmaceutical Contract Manufacturing Market Forecast by Drug Type, 2026-2036 (US$ Billion, AGR %)
- Figure 64 North America Pharmaceutical Contract Manufacturing Market Share Forecast by Drug Type, 2026 & 2036 (%)
- Figure 65 North America Pharmaceutical Contract Manufacturing Market Forecast by Services, 2026-2036 (US$ Billion, AGR %)
- Figure 66 North America Pharmaceutical Contract Manufacturing Market Share Forecast by Services, 2026 & 2036 (%)
- Figure 67 North America Pharmaceutical Contract Manufacturing Market Forecast by Scale of Operation, 2026-2036 (US$ Billion, AGR %)
- Figure 68 North America Pharmaceutical Contract Manufacturing Market Share Forecast by Scale of Operation, 2026 & 2036 (%)
- Figure 69 North America Pharmaceutical Contract Manufacturing Market Forecast by End-users, 2026-2036 (US$ Billion, AGR %)
- Figure 70 North America Pharmaceutical Contract Manufacturing Market Share Forecast by End-users, 2026 & 2036 (%)
- Figure 71 U.S. Pharmaceutical Contract Manufacturing Market Forecast, 2026-2036 (US$ Billion, AGR %)
- Figure 72 Canada Pharmaceutical Contract Manufacturing Market Forecast, 2026-2036 (US$ Billion, AGR %)
- Figure 73 Europe Pharmaceutical Contract Manufacturing Market Attractiveness Index
- Figure 74 Europe Pharmaceutical Contract Manufacturing Market by Region, 2026, 2031 & 2036 (US$ Billion)
- Figure 75 Europe Pharmaceutical Contract Manufacturing Market Forecast by Country, 2026-2036 (US$ Billion, AGR %)
- Figure 76 Europe Pharmaceutical Contract Manufacturing Market Share Forecast by Country, 2026 & 2036 (%)
- Figure 77 Europe Pharmaceutical Contract Manufacturing Market Forecast by Drug Type, 2026-2036 (US$ Billion, AGR %)
- Figure 78 Europe Pharmaceutical Contract Manufacturing Market Share Forecast by Drug Type, 2026 & 2036 (%)
- Figure 79 Europe Pharmaceutical Contract Manufacturing Market Forecast by Services, 2026-2036 (US$ Billion, AGR %)
- Figure 80 Europe Pharmaceutical Contract Manufacturing Market Share Forecast by Services, 2026 & 2036 (%)
- Figure 81 Europe Pharmaceutical Contract Manufacturing Market Forecast by Scale of Operation, 2026-2036 (US$ Billion, AGR %)
- Figure 82 Europe Pharmaceutical Contract Manufacturing Market Share Forecast by Scale of Operation, 2026 & 2036 (%)
- Figure 83 Europe Pharmaceutical Contract Manufacturing Market Forecast by End-users, 2026-2036 (US$ Billion, AGR %)
- Figure 84 Europe Pharmaceutical Contract Manufacturing Market Share Forecast by End-users, 2026 & 2036 (%)
- Figure 85 Germany Pharmaceutical Contract Manufacturing Market Forecast, 2026-2036 (US$ Billion, AGR %)
- Figure 86 UK Pharmaceutical Contract Manufacturing Market Forecast, 2026-2036 (US$ Billion, AGR %)
- Figure 87 France Pharmaceutical Contract Manufacturing Market Forecast, 2026-2036 (US$ Billion, AGR %)
- Figure 88 Italy Pharmaceutical Contract Manufacturing Market Forecast, 2026-2036 (US$ Billion, AGR %)
- Figure 89 Spain Pharmaceutical Contract Manufacturing Market Forecast, 2026-2036 (US$ Billion, AGR %)
- Figure 90 Rest of Europe Pharmaceutical Contract Manufacturing Market Forecast, 2026-2036 (US$ Billion, AGR %)
- Figure 91 Asia Pacific Pharmaceutical Contract Manufacturing Market Attractiveness Index
- Figure 92 Asia Pacific Pharmaceutical Contract Manufacturing Market by Region, 2026, 2031 & 2036 (US$ Billion)
- Figure 93 Asia Pacific Pharmaceutical Contract Manufacturing Market Forecast by Country, 2026-2036 (US$ Billion, AGR %)
- Figure 94 Asia Pacific Pharmaceutical Contract Manufacturing Market Share Forecast by Country, 2026 & 2036 (%)
- Figure 95 Asia Pacific Pharmaceutical Contract Manufacturing Market Forecast by Drug Type, 2026-2036 (US$ Billion, AGR %)
- Figure 96 Asia Pacific Pharmaceutical Contract Manufacturing Market Share Forecast by Drug Type, 2026 & 2036 (%)
- Figure 97 Asia Pacific Pharmaceutical Contract Manufacturing Market Forecast by Services, 2026-2036 (US$ Billion, AGR %)
- Figure 98 Asia Pacific Pharmaceutical Contract Manufacturing Market Share Forecast by Services, 2026 & 2036 (%)
- Figure 99 Asia Pacific Pharmaceutical Contract Manufacturing Market Forecast by Scale of Operation, 2026-2036 (US$ Billion, AGR %)
- Figure 100 Asia Pacific Pharmaceutical Contract Manufacturing Market Share Forecast by Scale of Operation, 2026 & 2036 (%)
- Figure 101 Asia Pacific Pharmaceutical Contract Manufacturing Market Forecast by End-users, 2026-2036 (US$ Billion, AGR %)
- Figure 102 Asia Pacific Pharmaceutical Contract Manufacturing Market Share Forecast by End-users, 2026 & 2036 (%)
- Figure 103 Japan Pharmaceutical Contract Manufacturing Market Forecast, 2026-2036 (US$ Billion, AGR %)
- Figure 104 China Pharmaceutical Contract Manufacturing Market Forecast, 2026-2036 (US$ Billion, AGR %)
- Figure 105 India Pharmaceutical Contract Manufacturing Market Forecast, 2026-2036 (US$ Billion, AGR %)
- Figure 106 Australia Pharmaceutical Contract Manufacturing Market Forecast, 2026-2036 (US$ Billion, AGR %)
- Figure 107 Rest of Asia Pacific Pharmaceutical Contract Manufacturing Market Forecast, 2026-2036 (US$ Billion, AGR %)
- Figure 108 Latin America Pharmaceutical Contract Manufacturing Market Attractiveness Index
- Figure 109 Latin America Pharmaceutical Contract Manufacturing Market by Region, 2026, 2031 & 2036 (US$ Billion)
- Figure 110 Latin America Pharmaceutical Contract Manufacturing Market Forecast by Country, 2026-2036 (US$ Billion, AGR %)
- Figure 111 Latin America Pharmaceutical Contract Manufacturing Market Share Forecast by Country, 2026 & 2036 (%)
- Figure 112 Latin America Pharmaceutical Contract Manufacturing Market Forecast by Drug Type, 2026-2036 (US$ Billion, AGR %)
- Figure 113 Latin America Pharmaceutical Contract Manufacturing Market Share Forecast by Drug Type, 2026 & 2036 (%)
- Figure 114 Latin America Pharmaceutical Contract Manufacturing Market Forecast by Services, 2026-2036 (US$ Billion, AGR %)
- Figure 115 Latin America Pharmaceutical Contract Manufacturing Market Share Forecast by Services, 2026 & 2036 (%)
- Figure 116 Latin America Pharmaceutical Contract Manufacturing Market Forecast by Scale of Operation, 2026-2036 (US$ Billion, AGR %)
- Figure 117 Latin America Pharmaceutical Contract Manufacturing Market Share Forecast by Scale of Operation, 2026 & 2036 (%)
- Figure 118 Latin America Pharmaceutical Contract Manufacturing Market Forecast by End-users, 2026-2036 (US$ Billion, AGR %)
- Figure 119 Latin America Pharmaceutical Contract Manufacturing Market Share Forecast by End-users, 2026 & 2036 (%)
- Figure 120 Brazil Pharmaceutical Contract Manufacturing Market Forecast, 2026-2036 (US$ Billion, AGR %)
- Figure 121 Mexico Pharmaceutical Contract Manufacturing Market Forecast, 2026-2036 (US$ Billion, AGR %)
- Figure 122 Rest of Latin America Pharmaceutical Contract Manufacturing Market Forecast, 2026-2036 (US$ Billion, AGR %)
- Figure 123 MEA Pharmaceutical Contract Manufacturing Market Attractiveness Index
- Figure 124 MEA Pharmaceutical Contract Manufacturing Market by Region, 2026, 2031 & 2036 (US$ Billion)
- Figure 125 MEA Pharmaceutical Contract Manufacturing Market Forecast by Country, 2026-2036 (US$ Billion, AGR %)
- Figure 126 MEA Pharmaceutical Contract Manufacturing Market Share Forecast by Country, 2026 & 2036 (%)
- Figure 127 MEA Pharmaceutical Contract Manufacturing Market Forecast by Drug Type, 2026-2036 (US$ Billion, AGR %)
- Figure 128 MEA Pharmaceutical Contract Manufacturing Market Share Forecast by Drug Type, 2026 & 2036 (%)
- Figure 129 MEA Pharmaceutical Contract Manufacturing Market Forecast by Services, 2026-2036 (US$ Billion, AGR %)
- Figure 130 MEA Pharmaceutical Contract Manufacturing Market Share Forecast by Services, 2026 & 2036 (%)
- Figure 131 MEA Pharmaceutical Contract Manufacturing Market Forecast by Scale of Operation, 2026-2036 (US$ Billion, AGR %)
- Figure 132 MEA Pharmaceutical Contract Manufacturing Market Share Forecast by Scale of Operation, 2026 & 2036 (%)
- Figure 133 MEA Pharmaceutical Contract Manufacturing Market Forecast by End-users, 2026-2036 (US$ Billion, AGR %)
- Figure 134 MEA Pharmaceutical Contract Manufacturing Market Share Forecast by End-users, 2026 & 2036 (%)
- Figure 135 GCC Pharmaceutical Contract Manufacturing Market Forecast, 2026-2036 (US$ Billion, AGR %)
- Figure 136 South Africa Pharmaceutical Contract Manufacturing Market Forecast, 2026-2036 (US$ Billion, AGR %)
- Figure 137 Rest of MEA Pharmaceutical Contract Manufacturing Market Forecast, 2026-2036 (US$ Billion, AGR %)
- Figure 138 Lonza: Net Revenue, 2021-2025 (US$ Million, AGR %)
- Figure 139 Lonza: R&D, 2021-2025 (US$ Million, AGR %)
- Figure 140 Lonza: Regional Market Shares (%), 2025
- Figure 141 Lonza: Business Segment Market Shares (%), 2025
- Figure 142 Catalent, Inc. (A Novo Holdings Company): Net Revenue, 2021-2024 (US$ Million, AGR %)
- Figure 143 Catalent, Inc. (A Novo Holdings Company): Regional Market Shares (%), 2024
- Figure 144 Catalent, Inc. (A Novo Holdings Company): Business Segment Market Shares (%), 2024
- Figure 145 AbbVie Inc.: Net Revenue, 2021-2025 (US$ Million, AGR %)
- Figure 146 AbbVie Inc.: R&D, 2021-2025 (US$ Million, AGR %)
- Figure 147 AbbVie Inc.: Regional Market Shares (%), 2025
- Figure 148 AbbVie Inc.: Business Segment Market Shares (%), 2025
- Figure 149 Thermo Fisher Scientific Inc.: Net Revenue, 2021-2025 (US$ Million, AGR %)
- Figure 150 Thermo Fisher Scientific Inc.: R&D, 2021-2025 (US$ Million, AGR %)
- Figure 151 Thermo Fisher Scientific Inc.: Regional Market Shares (%), 2025
- Figure 152 Thermo Fisher Scientific Inc.: Business Segment Market Shares (%), 2025
- Figure 153 Siegfried Holding AG: Net Revenue, 2021-2025 (US$ Million, AGR %)
- Figure 154 Siegfried Holding AG: Regional Market Shares (%), 2025
- Figure 155 Siegfried Holding AG: Business Segment Market Shares (%), 2025
- Figure 156 Evonik Industries AG: Net Revenue, 2021-2025 (US$ Million, AGR %)
- Figure 157 Evonik Industries AG: Regional Market Shares (%), 2025
- Figure 158 Evonik Industries AG: Business Segment Market Shares (%), 2025
- Figure 159 Boehringer Ingelheim International GmbH: Net Revenue, 2021-2025 (US$ Million, AGR %)
- Figure 160 Boehringer Ingelheim International GmbH: R&D, 2021-2025 (US$ Million, AGR %)
- Figure 161 Boehringer Ingelheim International GmbH: Regional Market Shares (%), 2025
- Figure 162 Boehringer Ingelheim International GmbH: Business Segment Market Shares (%), 2025
- Figure 163 Piramal Pharma Solutions.: Net Revenue, 2021-2025 (US$ Million, AGR %)
- Figure 164 Piramal Pharma Solutions: Business Segment Market Shares (%), 2025
- Figure 165 Samsung Biologics: Net Revenue, 2021-2025 (US$ Million, AGR %)
- Figure 166 WuXi AppTec: Net Revenue, 2021-2025 (US$ Million, AGR %)
- Figure 167 WuXi AppTec: Regional Market Shares (%), 2025
- Figure 168 WuXi AppTec: Business Segment Market Shares (%), 2025
- Figure 169 FUJIFILM Diosynth Biotechnologies: Net Revenue, 2021-2024 (US$ Million, AGR %)
- Figure 170 FUJIFILM Diosynth Biotechnologies: R&D, 2021-2024 (US$ Million, AGR %)
- Figure 171 ICON plc: Net Revenue, 2021-2024 (US$ Million, AGR %)
- Figure 172 ICON plc: Regional Market Shares (%), 2024
- Figure 173 Aenova Group: Net Revenue, 2021-2024 (US$ Million, AGR %)
- Figure 174 Aenova Group: Regional Market Shares (%), 2024
- Figure 175 Aenova Group: Business Segment Market Shares (%), 2024
- Figure 176 Nipro Pharma Corporation: Net Revenue, 2021-2025 (US$ Million, AGR %)
- Figure 177 Nipro Pharma Corporation: R&D, 2021-2025 (US$ Million, AGR %)
- Figure 178 Nipro Pharma Corporation: Regional Market Shares (%), 2025
- Figure 179 Nipro Pharma Corporation: Business Segment Market Shares (%), 2025
- Figure 180 Pfizer Inc.: Net Revenue, 2021-2025 (US$ Million, AGR %)
- Figure 181 Pfizer Inc.: R&D, 2021-2025 (US$ Million, AGR %)
- Figure 182 Pfizer Inc.: Regional Market Shares (%), 2025
- Figure 183 Pfizer Inc.: Business Segment Market Shares (%), 2025
- Figure 184 Grifols, S.A.: Net Revenue, 2021-2025 (US$ Million, AGR %)
- Figure 185 Grifols, S.A.: R&D, 2021-2025 (US$ Million, AGR %)
- Figure 186 Charles River Laboratories: Net Revenue, 2021-2025 (US$ Million, AGR %)
- Figure 187 Charles River Laboratories: Regional Market Shares (%), 2025
- Figure 188 Charles River Laboratories: Business Segment Market Shares (%), 2025
- Figure 189 IQVIA Inc.: Net Revenue, 2021-2025 (US$ Million, AGR %)
- Figure 190 IQVIA Inc.: Regional Market Shares (%), 2025
- Figure 191 IQVIA Inc.: Business Segment Market Shares (%), 2025
- Figure 192 Baxter: Net Revenue, 2021-2025 (US$ Million, AGR %)
- Figure 193 Baxter: R&D, 2021-2025 (US$ Million, AGR %)
- Figure 194 Baxter: Regional Market Shares (%), 2025
- Figure 195 Baxter: Business Segment Market Shares (%), 2025
- Figure 196 Eurofins Scientific: Net Revenue, 2021-2025 (US$ Million, AGR %)
- Figure 197 Nipro Pharma Corporation: Regional Market Shares (%), 2025
- Figure 198 Eurofins Scientific: Business Segment Market Shares (%), 2025
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.